In the case of GreenLight Laser Therapy, the most significant cost consideration should NOT be the device. It should be the fact that with its proven clinical benefits —decreased recovery time, shorter hospital stays and fewer serious adverse events—it may lead to overall lower hospital costs.1
A non-randomized study conducted in Ontario, Canada
in 2013 that compared the clinical-effectiveness, cost-effectiveness and budget impact of GreenLight Laser Therapy versus transurethral resection of the prostate (TURP).2
If the province of Ontario had used GreenLight therapy instead of TURP between fiscal years 2008/2009 and 2012/2013 (assuming 12,335 procedures in a 5 year time period), it could have seen a cost savings of over $14 million dollars. In addition, if performed on an outpatient basis, GreenLight Laser Therapy could have freed up over 28,000 days of inpatient care.
A multi-center, retrospective study conducted in Spain in 2013 that analyzed the costs of GreenLight Laser Therapy versus TURP.3
While the pre-surgical and surgical costs of the GreenLight procedure were shown to be higher than those related to TURP, its significantly lower post-surgical costs outweighed the initial investment and surgical cost per patient, ultimately resulting in GreenLight therapy being less expensive overall.
Our business model economic impact calculator helps you determine potential hospital costs and savings by switching your case mix of GreenLight therapy vs. TURP.4
If your facility’s administration is questioning the cost of the GreenLight technology, contact your local sales representative to schedule a review of the business impact model using data specific to your institution.